Predictive Oncology Inc. (POAI)

USD 0.73

(-1.35%)

Total Assets Summary of Predictive Oncology Inc.

  • Predictive Oncology Inc.'s latest annual total assets in 2023 was 14.41 Million USD , down -43.98% from previous year.
  • Predictive Oncology Inc.'s latest quarterly total assets in 2024 Q1 was 10.6 Million USD , down -26.47% from previous quarter.
  • Predictive Oncology Inc. reported annual total assets of 25.73 Million USD in 2022, down -41.21% from previous year.
  • Predictive Oncology Inc. reported annual total assets of 43.77 Million USD in 2021, up 235.14% from previous year.
  • Predictive Oncology Inc. reported quarterly total assets of 10.58 Million USD for 2024 Q2, down -0.13% from previous quarter.
  • Predictive Oncology Inc. reported quarterly total assets of 14.41 Million USD for 2023 FY, down -43.98% from previous quarter.

Annual Total Assets Chart of Predictive Oncology Inc. (2023 - 2008)

Historical Annual Total Assets of Predictive Oncology Inc. (2023 - 2008)

Year Total Assets Total Assets Growth
2023 14.41 Million USD -43.98%
2022 25.73 Million USD -41.21%
2021 43.77 Million USD 235.14%
2020 13.06 Million USD -41.63%
2019 22.37 Million USD 503.28%
2018 3.7 Million USD 2.34%
2017 3.62 Million USD 29.09%
2016 2.8 Million USD -50.15%
2015 5.63 Million USD 525.15%
2014 900.97 Thousand USD 51.83%
2013 593.42 Thousand USD 60.57%
2012 369.57 Thousand USD -17.18%
2011 446.22 Thousand USD 169.01%
2010 165.87 Thousand USD -42.86%
2009 290.29 Thousand USD -63.21%
2008 788.97 Thousand USD 0.0%

Peer Total Assets Comparison of Predictive Oncology Inc.

Name Total Assets Total Assets Difference
Akoya Biosciences, Inc. 180.36 Million USD 92.007%
AngioDynamics, Inc. 317.67 Million USD 95.462%
AtriCure, Inc. 613.93 Million USD 97.652%
Avinger, Inc. 13.77 Million USD -4.7%
Azenta, Inc. 2.88 Billion USD 99.5%
BioLife Solutions, Inc. 412.71 Million USD 96.507%
The Cooper Companies, Inc. 11.65 Billion USD 99.876%
Daxor Corporation 34.86 Million USD 58.653%
Ekso Bionics Holdings, Inc. 28.91 Million USD 50.144%
Femasys Inc. 27.75 Million USD 48.057%
GlucoTrack, Inc. 4.9 Million USD -193.93%
Harvard Bioscience, Inc. 137.36 Million USD 89.504%
Hologic, Inc. 9.15 Billion USD 99.843%
ICU Medical, Inc. 4.37 Billion USD 99.671%
Intuitive Surgical, Inc. 15.44 Billion USD 99.907%
KORU Medical Systems, Inc. 28.46 Million USD 49.344%
LeMaitre Vascular, Inc. 346.77 Million USD 95.843%
Innovative Eyewear, Inc. 6.21 Million USD -131.835%
Innovative Eyewear, Inc. 6.21 Million USD -131.835%
Masimo Corporation 3.04 Billion USD 99.526%
Microbot Medical Inc. 8.32 Million USD -73.139%
Meihua International Medical Technologies Co., Ltd. 171.91 Million USD 91.614%
Merit Medical Systems, Inc. 2.32 Billion USD 99.38%
Nephros, Inc. 11.86 Million USD -21.552%
NovoCure Limited 1.14 Billion USD 98.742%
NEXGEL, Inc. 9.95 Million USD -44.824%
NEXGEL, Inc. 9.95 Million USD -44.824%
Singular Genomics Systems, Inc. 265.46 Million USD 94.569%
OraSure Technologies, Inc. 482.84 Million USD 97.014%
Pro-Dex, Inc. 54.21 Million USD 73.405%
Pulse Biosciences, Inc. 60.8 Million USD 76.289%
Precision Optics Corporation, Inc. 16.91 Million USD 14.754%
QuidelOrtho Corporation 8.56 Billion USD 99.832%
Repligen Corporation 2.82 Billion USD 99.49%
Sanara MedTech Inc. 73.87 Million USD 80.483%
STAAR Surgical Company 488.69 Million USD 97.05%
Sharps Technology, Inc. 11.78 Million USD -22.291%
Utah Medical Products, Inc. 135.45 Million USD 89.357%
DENTSPLY SIRONA Inc. 7.37 Billion USD 99.804%
Jin Medical International Ltd. 32.9 Million USD 56.183%